about
Solid-phase synthesis of a combinatorial library of dihydroceramide analogues and its activity in human alveolar epithelial cells.Synthesis of lipid-oligonucleotide conjugates for RNA interference studies.Transfection of Antisense Oligonucleotides Mediated by Cationic Vesicles Based on Non-Ionic Surfactant and Polycations Bearing Quaternary Ammonium Moieties.Double-tailed lipid modification as a promising candidate for oligonucleotide delivery in mammalian cells.Oligonucleotide delivery: a patent review (2010 - 2013).Lipid-modified oligonucleotide conjugates: Insights into gene silencing, interaction with model membranes and cellular uptake mechanisms.Biodegradable liposome-encapsulated hydrogels for biomedical applications: a marriage of convenience.The role of helper lipids in the intracellular disposition and transfection efficiency of niosome formulations for gene delivery to retinal pigment epithelial cells.The influence of the polar head-group of synthetic cationic lipids on the transfection efficiency mediated by niosomes in rat retina and brain.New Insights into Gene Delivery to Human Neuronal Precursor NT2 Cells: A Comparative Study between Lipoplexes, Nioplexes, and Polyplexes.Protamine/DNA/Niosome Ternary Nonviral Vectors for Gene Delivery to the Retina: The Role of Protamine.Novel non-viral gene delivery systems composed of carbosilane dendron functionalized nanoparticles prepared from nano-emulsions as non-viral carriers for antisense oligonucleotides.A novel formulation based on 2,3-di(tetradecyloxy)propan-1-amine cationic lipid combined with polysorbate 80 for efficient gene delivery to the retina.A novel cationic niosome formulation for gene delivery to the retina.Oligonucleotide-Lipid Conjugates Forming G-Quadruplex Structures Are Potent and Pangenotypic Hepatitis C Virus Entry Inhibitors In Vitro and Ex Vivo.Niosomes based on synthetic cationic lipids for gene delivery: the influence of polar head-groups on the transfection efficiency in HEK-293, ARPE-19 and MSC-D1 cells.Cationic vesicles based on non-ionic surfactant and synthetic aminolipids mediate delivery of antisense oligonucleotides into mammalian cells.Synthesis of oligonucleotides carrying amino lipid groups at the 3'-end for RNA interference studies.Stem cell-based gene delivery mediated by cationic niosomes for bone regeneration.Boronic acid-modified alginate enables direct formation of injectable, self-healing and multistimuli-responsive hydrogels.Isosteric Substitution of 4H-1,2,4-Triazole by 1H-1,2,3-Triazole in Isophthalic Derivative Enabled Hydrogel Formation for Controlled Drug Delivery.Covalent Strategies for Targeting Messenger and Non-Coding RNAs: An Updated Review on siRNA, miRNA and antimiR Conjugates.Direct covalent attachment of DNA microarrays by rapid thiol-ene "click" chemistry.Synthesis of oligonucleotides carrying fluorescently labelled O(6)-alkylguanine for measuring hAGT activity.Exploring PAZ/3'-overhang interaction to improve siRNA specificity. A combined experimental and modeling study.Synthesis of oligonucleotide-peptide conjugates for biomedical and technological applicationsSynthesis of oligonucleotides carrying thiol groups using a simple reagent derived from threoninolThioctic acid derivatives as building blocks to incorporate DNA oligonucleotides onto gold nanoparticlesAlginate Hydrogels as Scaffolds and Delivery Systems to Repair the Damaged Spinal CordMagnetic Gel Composites for Hyperthermia Cancer Therapy
P50
Q33262553-D603348F-2802-47F5-9839-825CAB7C58CEQ33825496-0791E85D-E221-42E4-AEB9-F149A78E068AQ33838476-002BCA63-F159-4F49-AB85-567320FAC7FEQ34783930-D479F4E8-379C-42DA-9515-42FB38343333Q35163373-B873E2EB-6F96-4351-B9A5-FE39218F8A82Q38290258-1E20745A-9E2E-4BA0-94D0-FAD2566D591DQ38714425-7829833C-DF7E-426C-84EC-87E1D0682B56Q38787865-D2DB5C3B-4780-43A6-A5E6-DE2236ED539BQ38816429-9DFA556A-D4B9-495B-BBC5-467DF9FFC5A1Q38832489-D5313656-7F7F-49A1-9AD5-CE19DBBAAE37Q38838421-B993BB7E-C9C7-4554-BF1E-947CFD3F1EA1Q38935199-E5637B5D-FD98-442B-979B-3A44FB0F6E87Q39032036-DD913B37-EFCF-4EF3-8247-8E7BE5E4B1A7Q39063156-61AF13CE-3ECF-4CA2-B599-91453FD4E42BQ40334457-A59B02D4-4B8F-4A32-8C47-F57D19F1857CQ42181014-B97477C5-2A15-40EA-ABC1-4840CF73FFD4Q42216766-9300E9BA-9F41-49F3-A481-44AA24CC24C9Q42878516-6FA06411-85CC-4633-821B-1ABEE5DD8AE7Q45874763-7BB66449-4162-40D7-BC23-B4F290D44F2BQ48163464-8834F675-8D1F-4165-8D12-DE220C0E1E93Q49982455-67D5237A-BEA0-4A09-B53C-6B4D83FC2860Q50131778-5DB37620-7DDF-4B7D-9977-C3E3A1AEC4DCQ51752103-272666E1-A371-4151-B6D6-A4F28A19EDC9Q53813859-F7416423-BE80-4970-9ACC-9E42B76EEC03Q55302171-B7B9359D-0FE9-4972-A5C8-48B22CED224BQ84364656-157FCDC2-F646-425D-AD84-F4501EFDA71FQ84869796-6E73C29A-3810-41A7-B901-EFB470716EF9Q87419989-6498AC7E-40BB-428B-9A5B-DAD7A533FEEAQ91064769-882599E4-5695-4F54-8D87-319BA408BBC5Q91184016-0094892F-C42E-420A-BB77-472BF0DEFC3E
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Santiago Grijalvo
@ast
Santiago Grijalvo
@en
Santiago Grijalvo
@es
Santiago Grijalvo
@nl
Santiago Grijalvo
@sl
type
label
Santiago Grijalvo
@ast
Santiago Grijalvo
@en
Santiago Grijalvo
@es
Santiago Grijalvo
@nl
Santiago Grijalvo
@sl
prefLabel
Santiago Grijalvo
@ast
Santiago Grijalvo
@en
Santiago Grijalvo
@es
Santiago Grijalvo
@nl
Santiago Grijalvo
@sl
P106
P21
P31
P496
0000-0002-8405-4844